Literature DB >> 27529406

FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.

Pawel Tacik1, Michael A DeTure2, Yari Carlomagno2, Wen-Lang Lin2, Melissa E Murray2, Matthew C Baker2, Keith A Josephs3, Bradley F Boeve3, Zbigniew K Wszolek1, Neill R Graff-Radford1, Joseph E Parisi4, Leonard Petrucelli2, Rosa Rademakers2, Richard S Isaacson5, Kenneth M Heilman6, Ronald C Petersen3, Dennis W Dickson2, Naomi Kouri2.   

Abstract

Mutations in microtubule-associated protein tau gene (MAPT) cause frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). Here, we describe a patient with FTDP-17 and a novel missense mutation in exon 13 of MAPT, p.E372G. We compare clinicopathologic features of this patient to two previously unreported patients with another exon 13 mutation, p.G389R. The patient with the p.E372G mutation was a 40-year-old man with behavioral variant frontotemporal dementia (bvFTD), who subsequently developed agrammatic speech and parkinsonism. One of the FTDP-17 patients with p.G389R mutation presented at age 24 with agrammatic variant of primary progressive aphasia, and subsequently behavioral dysfunction. The other presented at age 53 with bvFTD, followed by agrammatic speech and corticobasal syndrome. Neuropathologic features of FTDP-17 due to p.E372G were similar to those of p.G389R, including tau-immunoreactive Pick body-like neuronal inclusions and swollen, tapering thread-like processes in white matter immunoreactive for 3-repeat and 4-repeat tau. Biochemical analysis of insoluble tau showed similar isoform compositions in p.E372G and p.G389R. Functional studies of the p.E372G mutation showed marked increase in tau filament formation and its reduced ability to promote microtubule assembly. Together these findings indicate that p.E372G is a pathogenic MAPT mutation that causes FTDP-17 similar to p.G389R.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  FTDP-17; MAPT mutations; Pick's disease; frontotemporal dementia; primary progressive aphasia

Mesh:

Substances:

Year:  2016        PMID: 27529406      PMCID: PMC5380645          DOI: 10.1111/bpa.12428

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  34 in total

1.  Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.

Authors:  Bradley F Boeve; Ivo W Tremont-Lukats; Andrew J Waclawik; Jill R Murrell; Bruce Hermann; Clifford R Jack; Maria M Shiung; Glenn E Smith; Anil R Nair; Noralane Lindor; Vinaya Koppikar; Bernardino Ghetti
Journal:  Brain       Date:  2004-12-22       Impact factor: 13.501

2.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

Authors:  M Hong; V Zhukareva; V Vogelsberg-Ragaglia; Z Wszolek; L Reed; B I Miller; D H Geschwind; T D Bird; D McKeel; A Goate; J C Morris; K C Wilhelmsen; G D Schellenberg; J Q Trojanowski; V M Lee
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

3.  Early-onset, rapidly progressive familial tauopathy with R406W mutation.

Authors:  Y Saito; A Geyer; R Sasaki; S Kuzuhara; E Nanba; T Miyasaka; K Suzuki; S Murayama
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

4.  Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.

Authors:  P Nacharaju; J Lewis; C Easson; S Yen; J Hackett; M Hutton; S H Yen
Journal:  FEBS Lett       Date:  1999-03-26       Impact factor: 4.124

5.  Autosomal dominant dementia with widespread neurofibrillary tangles.

Authors:  L A Reed; T J Grabowski; M L Schmidt; J C Morris; A Goate; A Solodkin; G W Van Hoesen; R L Schelper; C J Talbot; M A Wragg; J Q Trojanowski
Journal:  Ann Neurol       Date:  1997-10       Impact factor: 10.422

6.  Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.

Authors:  J R Murrell; M G Spillantini; P Zolo; M Guazzelli; M J Smith; M Hasegawa; F Redi; R A Crowther; P Pietrini; B Ghetti; M Goedert
Journal:  J Neuropathol Exp Neurol       Date:  1999-12       Impact factor: 3.685

7.  Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.

Authors:  T Lynch; M Sano; K S Marder; K L Bell; N L Foster; R F Defendini; A A Sima; C Keohane; T G Nygaard; S Fahn
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

8.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Slowly progressive behavioural presentation in two UK cases with the R406W MAPT mutation.

Authors:  R Wood; K Moodley; J R Hodges; K Allinson; M G Spillantini; D Chan
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-30       Impact factor: 8.090

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  6 in total

1.  Heterogeneous Tau-Tubulin Complexes Accelerate Microtubule Polymerization.

Authors:  Xiao-Han Li; Elizabeth Rhoades
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

Review 2.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

3.  Genetic screen in a large series of patients with primary progressive aphasia.

Authors:  Eliana Marisa Ramos; Deepika Reddy Dokuru; Victoria Van Berlo; Kevin Wojta; Qing Wang; Alden Y Huang; Zachary A Miller; Anna M Karydas; Eileen H Bigio; Emily Rogalski; Sandra Weintraub; Benjamin Rader; Bruce L Miller; Maria Luisa Gorno-Tempini; Marek-Marsel Mesulam; Giovanni Coppola
Journal:  Alzheimers Dement       Date:  2019-01-25       Impact factor: 21.566

4.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

5.  Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia.

Authors:  Rachelle Shafei; Ione O C Woollacott; Catherine J Mummery; Martina Bocchetta; Rita Guerreiro; Jose Bras; Jason D Warren; Tammaryn Lashley; Zane Jaunmuktane; Jonathan D Rohrer
Journal:  Neurobiol Aging       Date:  2019-11-20       Impact factor: 4.673

Review 6.  Cellular and pathological heterogeneity of primary tauopathies.

Authors:  Dah-Eun Chloe Chung; Shanu Roemer; Leonard Petrucelli; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2021-08-23       Impact factor: 18.879

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.